IngenBio Corp. Application Registration Disclaimer
Please read the following disclaimer, and verify your acceptance by checking the "I have read and accept this agreement" box at the bottom.
Welcome to IngenBio Corp.
At IngenBio, we aspire to be the leading private human pharmaceutical development company in the world. Our goal is to meet the pharmaceutical industry's increasing demands for more effectively targeted research and medicine. High-quality people make a strong, dynamic company. IngenBio understands this truth. Achieving our goal starts with building the best R&D organization.
As we look for talent to help shape our future, we ask our applicants some of the following questions: Do you appreciate the value of a shared purpose, and would you commit to that desired end? Do you understand high-quality and lasting relationships may require substantial effort? Do you act decisively and use sound judgment? Do you want your work to have an impact and be noticed? Do you want a career where you can share your knowledge and build knowledge from conversations with others?
Public and private research and academic institutions and private companies, both in the United States and in other countries, including on-federal U.S. and non-U.S. governmental organizations, have their own specific policies related to the protection of human participants in research. Much of the scientific information supporting EPA's actions is generated by researchers who are not part of or supported by a Federal agency, including a significant portion of the research with human subjects submitted to the Agency or retrieved by the Agency from published sources. Such research, referred to here as "third-party" research, may be governed by specific institutional policies intended to protect research participants, may fall within the scope of the Declaration of Helsinki, or might actually be covered by the Common Rule if the particular testing institution holds an assurance approved for federal-wide use by the Department of Health and Human Services' (HHS) Office for Human Research Protections and the institution has voluntarily extended the applicability of the assurance to such research. In some instances, research is reported in such a manner that EPA cannot readily determine whether institutional policies are consistent with or as protective of human subjects as the Common Rule, or even the extent to which such policies or standards have been followed in the conduct of any particular study. Thus, even well-conducted third-party human studies may raise difficult questions for the Agency when it seeks to determine their acceptability for consideration. Unit IV. of this Notice contains a description of EPA's case-by-case process for review of third-party human studies.
Our progress is based on research which ultimately must rest in part on experimentation involving human subjects. As part of your application process, you may be subject to human testing, control group diagnostics, and monitored surveillance.
Our practices may not adhere to the World Medical Association guidelines for Human testing and the World Medical Association Declaration of Helsinki http://www.wma.net/e/policy/b3.htm
The information on IngenBio is not to be used for diagnosing or treating health problems, disease, or prescribing medication or other treatment. Always consult your physician or other healthcare professional before taking Intragen(R), any medication or nutraceutical, herbal or homeopathic supplement, or adopting any treatment.
For products or services mentioned or suggested on IngenBio, read carefully all product packaging and instructions. If you have or suspect that you have a medical problem, promptly contact your health care provider. Never disregard professional medical advice or delay in seeking professional advice because of something you have read on IngenBio. Information provided on IngenBio and the use of any products or services on IngenBio by you DOES NOT create a doctor-patient relationship between you and any of the physicians or other healthcare professionals affiliated with IngenBio. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. If you do anything recommended on this web site, without the supervision of a licensed medical doctor, you do so at your own risk.
Reference to any specific agencies, commercial products, processes, or services by trade name, trademark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by the U.S. Government.
Rare events of adult immune distress syndrome, lymphatic rupture, and neural crises have been reported in post-marketing experience in patients receiving INTRAGEN(R).
IngenBio Corporation, in is sole discretion, reserves the right to disqualify any person tampering with the applicant process, the operation of the IngenBio Corporation Web Site or is otherwise in violation of the rules. It further reserves the right to cancel, terminate or modify the applicant account if it is not capable of completion as planned, including infection by computer virus, bugs, tampering, unauthorized intervention or technical failures of any sort. Any attempt by an applicant or any other individual or group to deliberately damage any online service or Web site, tamper with the applicant submission/file upload process, or otherwise undermine the legitimate operation of the applicant process is a violation of criminal and civil laws and should such an attempt be made, IngenBio reserves the right to seek damages and/or other remedies from any such person or group to the fullest extent permitted by law. Failure to enforce any term of these rules shall not constitute a waiver of that provision. If for any reason the applicant process is not capable of being executed as planned, or infection by computer virus, bugs, tampering, unauthorized intervention, fraud, action of entrants, technical failures or any other causes beyond the control of IngenBio, corrupts or affects the administration, security, integrity, or proper conduct of this applicant process, IngenBio reserves the right at its sole discretion to disqualify any suspect Applicant and to cancel, terminate, modify or suspend the applicant process. Applicants not complying with all rules are subject to disqualification. IngenBio retains right to modify terms at any time, for any reason.
INGEN BIO Corporation
Making your future better...today.
|